Jump to content

Vaccine- who will have it?


Banker

Recommended Posts

1 hour ago, madmanxpilot said:

The WHO scientists will be peers in their own right. They've not allegedly said it, they have said it.  

https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know

 

They won't have made that pronouncement without a thorough review of available data. The manufacturer has recommended increasing the dosing interval.  

https://www.astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html

 

Surely the IOM will 'follow the science' and adapt it's own dosing strategy accordingly.

WHO don’t peer review. They comment and advise on the trials and preliminary results and peer reviewed results. 
 

The manufacturer has not recommended increasing the interval. It’s commented on the data interpretation from the provisional results.

None of this is peer reviewed or recommended by the manufacturer. They hope it will be, but that’s not guaranteed.

Link to comment
Share on other sites

14 minutes ago, John Wright said:

WHO don’t peer review. They comment and advise on the trials and preliminary results and peer reviewed results. 
 

The manufacturer has not recommended increasing the interval. It’s commented on the data interpretation from the provisional results.

None of this is peer reviewed or recommended by the manufacturer. They hope it will be, but that’s not guaranteed.

That’s true but it is currently being reviewed and the Lancet has made it available as a pre-print version online, so I suspect that they are confident it will go to print after the review. The authors are the same ones who produced the original paper that allowed them to get emergency authorisation for use from the regulators in the UK. I don’t suppose it will be long before it is published 

Link to comment
Share on other sites

17 minutes ago, John Wright said:

WHO don’t peer review. They comment and advise on the trials and preliminary results and peer reviewed results. 
 

The manufacturer has not recommended increasing the interval. It’s commented on the data interpretation from the provisional results.

None of this is peer reviewed or recommended by the manufacturer. They hope it will be, but that’s not guaranteed.

There's nothing special about peer review.  A journal such as the Lancet will have a bank of people who act as reviewers for articles (I've done it myself - not for the Lancet, admittedly) and usually ask 3 to blindly review submissions for publication.  By blindly I mean without sight of the authors or the institution that produced the work.  For something such as a covid vaccine paper that is so high profile it will be obvious to anyone in the field where the paper's come from so the blinding aspect is not really relevant.  If the 3 reviewers, or maybe 2/3, recommend publication it's in.  That's peer review.  I've seen some rubbish published in medical journals in my time, when the reviewers haven't bothered (or didn't understand) to scrutinise statistical methods etc.  I'd argue that a positive recommendation from the WHO SAGE panel is stronger than 'peer review'.

Manufacturers rarely recommend dosing intervals etc.  Most of them like to be seen to be independent and concentrate on making the stuff while the scientists and medics make pronouncements on timing etc based on the studies' results.

 

  • Like 2
Link to comment
Share on other sites

5 minutes ago, wrighty said:

For something such as a covid vaccine paper that is so high profile it will be obvious to anyone in the field where the paper's come from so the blinding aspect is not really relevant. 

Great restraint not using the phrase ‘blindingly obvious’!

Link to comment
Share on other sites

20 minutes ago, wrighty said:

 

Manufacturers rarely recommend dosing intervals etc.  Most of them like to be seen to be independent and concentrate on making the stuff while the scientists and medics make pronouncements on timing etc based on the studies' results.

 

This is correct and has been said on here (by me and others) before, that vaccine developers cannot possibly test the application rates at every interval. If they did they would still be testing them now.

That's why I don't get our dogmatic approach. Yes aim for 3 weeks but stop worrying if 3 becomes 4 or 5 or 6 due to supply restriction. It doesn't matter a ****. Might turn out 4 or 5 or 6 (or more) was the best anyway.

All programmes, be they building or vaccination, run better if you take some risk and don't rigidly apply/constrain dates and times. Any constraint will slow a programme down. 

  • Like 3
Link to comment
Share on other sites

2 hours ago, madmanxpilot said:

The WHO scientists will be peers in their own right. They've not allegedly said it, they have said it.  

https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know

 

They won't have made that pronouncement without a thorough review of available data. The manufacturer has recommended increasing the dosing interval.  

https://www.astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html

 

Surely the IOM will 'follow the science' and adapt it's own dosing strategy accordingly.

Manx solutions 😀 we’re the only ones in UK including Channel Islands continuing with this 3 weeks intervals when it appears better immunity from 6-12 weeks 

  • Like 1
Link to comment
Share on other sites

12 minutes ago, Banker said:

Manx solutions 😀 we’re the only ones in UK including Channel Islands continuing with this 3 weeks intervals when it appears better immunity from 6-12 weeks 

How do they know, when they have not tried 3 weeks except in trials? 

Andrew Lloyd Webber was on TV this morning saying he had the Pfizer vaccine 3 weeks apart as part of the trials 8 months ago and still has very high levels of immunity. I think I will take mine based on manufacturers recommendation. 

  • Like 1
Link to comment
Share on other sites

1 hour ago, John Wright said:

WHO don’t peer review. They comment and advise on the trials and preliminary results and peer reviewed results. 
 

The manufacturer has not recommended increasing the interval. It’s commented on the data interpretation from the provisional results.

None of this is peer reviewed or recommended by the manufacturer. They hope it will be, but that’s not guaranteed.


A peer review is the evaluation of work by one or more people with similar competencies as the producers of the work (peers). Surely the WHO scientist's review of the AZ data constitutes peer review?

AZ have said, officially, that the jab is more efficent if the vaccine is given at a greater interval than was originally suggested. How is that not a  recomendation?
Edited by madmanxpilot
Link to comment
Share on other sites

34 minutes ago, Cambon said:

How do they know, when they have not tried 3 weeks except in trials? 

Andrew Lloyd Webber was on TV this morning saying he had the Pfizer vaccine 3 weeks apart as part of the trials 8 months ago and still has very high levels of immunity. I think I will take mine based on manufacturers recommendation. 

As previously posted on here today , I think by Wrighty, manufacturers don’t recommend doses intervals that’s upto government eg JCVI in UK but their stance has been endorsed by WHO so I’ll take that over Ashie decision  

Link to comment
Share on other sites

22 minutes ago, Banker said:

As previously posted on here today , I think by Wrighty, manufacturers don’t recommend doses intervals that’s upto government eg JCVI in UK but their stance has been endorsed by WHO so I’ll take that over Ashie decision  

You may be getting the two vaccines mixed up.  Cambon was referring to the Pfizer one and the current WHO guidelines (download) say the doses should be 21-28 days apart[1].  In extreme circumstances governments may decide that the gap can be increased to up to 42 days, but care must be taken that this doesn't lead to second doses being missed.

This reflects the gaps that were used in the trials which were 18-42 days.

 

[1]  The exactly 21 days thing was a typical piece of Ashford magical thinking.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...